NVO Operating Cash Flow (Statement)

Novo Nordisk A/S Common Stock · Operating Cash Flow (Statement)

NVO logo

NVO Operating Cash Flow (Statement)

Latest reportedkr 133.01B DKK
NVO TTM Cash from Operations · DKK (kr 7.64B → kr 133.01B)
High-resolution chart · PNG

NVO operating cash flow (statement) history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (DKK)
Period endingOperating Cash Flow (Statement) (DKK)
133,009,000,000
118,595,000,000
119,102,000,000
123,784,000,000
121,527,000,000
131,245,000,000
120,968,000,000
118,218,000,000
115,334,000,000
93,408,000,000
108,908,000,000
106,458,000,000
89,731,000,000
85,115,000,000
78,887,000,000
68,769,000,000
66,037,000,000
67,331,000,000
55,000,000,000
58,189,000,000
54,188,000,000
53,194,000,000
51,951,000,000
56,944,000,000
56,126,000,000
46,904,000,000
46,782,000,000
49,029,000,000
43,960,000,000
44,691,000,000
44,616,000,000
43,236,000,000
44,538,000,000
38,885,000,000
41,168,000,000
46,289,000,000
48,557,000,000
52,937,000,000
48,314,000,000
47,280,000,000
44,179,000,000
41,656,000,000
38,287,000,000
35,469,000,000
35,578,000,000
31,729,000,000
31,692,000,000
29,763,000,000
23,783,000,000
22,941,000,000
25,942,000,000
22,084,000,000
23,829,000,000
22,369,000,000
22,214,000,000
24,681,000,000
24,473,000,000
23,181,000,000
21,374,000,000
22,298,000,000
20,862,000,000
20,556,000,000
19,679,000,000
18,357,000,000
17,078,000,000
15,461,000,000
15,378,000,000
15,038,498,150
13,662,446,000
13,975,978,700
12,896,921,200
12,166,590,750
11,994,728,100
10,516,304,640
9,997,870,000
7,844,101,750
7,876,285,500
8,198,738,860
7,741,322,000
9,735,643,650
9,117,808,450
9,447,712,860
8,699,492,400
8,448,745,490
8,025,924,900
7,648,068,090
7,644,519,330
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.